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Background: Streptococcus suis, more specifically serotype 2, is a major swine pathogen and an emerging zoonotic
agent that causes severe infections such as meningitis, endocarditis, and septicemia. In this study, surface-enhanced
laser desorption/ionization time-of-flight mass spectrometry (SELDI) was used to investigate the protein expression
profiles of 45 strains of S. suis serotype 2 that had previously been clustered by multilocus sequence typing (MLST)
into three sequence types (ST1, ST25, and ST28) (n = 15 for each ST).
Results: The SELDI data were analyzed using the univariate Mann–Whitney and Kruskal-Wallis tests and multivariate
statistical methods (heatmap/hierarchical clustering). The heatmap identified 136 cell proteins, and hierarchical
clustering provided a 100% correct classification of all fifteen ST1 and ST25 strains and thirteen of the fifteen ST28
strains (87% correct). The univariate statistical analyses of the SELDI protein expression profiles identified nine
significant proteins that discriminated the strains of the three STs of S. suis. Of these proteins, two were overexpressed
in ST1 (5958 Da and 10249 Da), four in ST25 (5989 Da, 6646 Da, 7421 Da, and 9825 Da), and three in ST28 (4516 Da,
7833 Da, and 9342 Da). Two of the proteins associated with the ST28 strains (p4516 and p9342) were purified and were
identified as a putative ABC transporter and a nucleoid-DNA-binding protein, respectively.
Conclusions: SELDI analysis of 45 strains of S. suis allowed to identify nine statistically significant proteins that can be
specifically correlated with either ST1, ST25 or ST28. The possible involvement of the overexpressed proteins in the
pathology of S. suis infections will require further investigation.
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Streptococcus suis, more particularly serotype 2, is a
major swine pathogen and an emerging zoonotic agent.
In Western countries it mainly affects individuals with
occupational exposure to pigs who are in direct contact
with farm animals or who handle pork meat and carcasses
[1,2]. Zoonotic infections caused by S. suis are encoun-
tered more frequently in East Asia (China, Vietnam,
Cambodia, Thailand, Hong Kong) where the general
population is also at risk due to backyard food production* Correspondence: daniel.grenier@greb.ulaval.ca
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unless otherwise stated.systems, wet markets, and/or consumption of raw pork
meat/blood [1-3]. Porcine and human infections can be
severe, with meningitis, endocarditis, and septicemia as
possible clinical outcomes [3,4]. In humans, mortalities
ranging from 5% to 20% have been reported [1,5].
S. suis is a Gram-positive bacterium with cell wall anti-
genic determinants somehow related to Lancefield group
D streptococci [4]. Currently, 33 serotypes have been de-
scribed based on the composition of their capsular poly-
saccharides [2]. While the serotype distribution varies
depending on the geographical origin of the strains, S.
suis serotype 2 is considered the most pathogenic and
the most prevalent capsular type among diseased pigs
and humans [2,6,7]. Multilocus sequence typing (MLST)
has shown that S. suis serotype 2 strains can be divided
into different sequence types (STs) [8]. Closely related
STs are grouped in ST complexes, and several dominateral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Atanassov et al. BMC Microbiology  (2015) 15:84 Page 2 of 9the S. suis population, including ST1, ST16, ST25, ST28,
and ST147. Most invasive strains causing human out-
breaks in Europe and Asia are ST1 strains [9-11] or, at
least, belong to the ST1 and ST16 complexes [8,12-14].
This is in agreement with the recent study by Fittipaldi
et al. [15], who showed, using a mouse infection model,
that European ST1 strains are highly virulent while North
American ST25 strains display moderate virulence and
North American ST28 strains are weakly virulent.
The reasons for these differences in virulence are not
well understood [15] while the discovery of novel candi-
date virulence factors that are either produced exclu-
sively or overexpressed by ST1 strains is a major
theoretical and practical issue. The search for putative S.
suis virulence factors has been conducted using genomic
[16-22] and proteomic tools [23-31]. Proteomic studies
of S. suis are based on the initial separation of bacterial
proteins by two-dimensional polyacrylamide gel electro-
phoresis (2D PAGE) followed by the enzymatic digestion
of selected protein bands and the identification of the
resulting peptides by mass spectrometry combined with
bio-informatics analyses of databases of sequenced ge-
nomes from this taxon. While proteomic methods have
made a major contribution, they suffer from limitations
inherent to 2D electrophoresis, which often fails to de-
tect some proteins, especially those with small molecular
weights or extreme isoelectric points. These limitations
can be overcome using surface-enhanced laser desorp-
tion/ionization time-of-flight mass spectrometry (SELDI-
TOF-MS; SELDI ProteinChip), a medium-throughput
technology that allows protein expression levels in hun-
dreds of samples in a single experiment to be compared
[32,33]. We used this approach to analyze 45 S. suis sero-
type 2 strains and found nine statistically significant pro-
teins correlated to the three STs that had previously been
identified by MLST (ST1, ST25, and ST28). Moreover,
two of these biomarkers were purified and identified.
Methods
Bacterial strains
Forty-five S. suis serotype 2 strains isolated from dis-
eased pigs or humans from different countries were in-
cluded in the SELDI analysis. They were either ST1,
ST25, or ST28 strains (see Table 1) based on previous
MLST analyses ([15], unpublished data).
Preparation of bacterial cells
All S. suis strains were grown in parallel at 37°C in
10 ml of Todd-Hewitt broth (BBL Microbiology Sys-
tems, Cockeysville, MD, USA) until they reached an op-
tical density (660 nm) in the range of 0.4 to 0.5
corresponding to the mid-log phase. The bacterial cells
were harvested by centrifugation at 3,000 × g for 10 min
at 4°C. The cell pellets were washed three times in50 mM phosphate-buffered saline (pH 7.4) (PBS) supple-
mented ex tempore with 2 mM 4-(2-aminoethyl)benzene-
sulfonyl fluoride hydrochloride (AEBSF; Sigma-Aldrich
Canada, Oakville, ON, Canada). After centrifugation at
3,000 × g for 10 min at 4°C, the cell pellets were immedi-
ately stored at −80°C until used.
Protein extraction
The frozen cell pellets were thawed and were individu-
ally suspended in 1 ml of lysis buffer (16 mM Na2HPO4,
4 mM NaH2PO4, 150 mM NaCl, 1% Triton X-100) sup-
plemented with cOmplete protease inhibitor cocktail®
(Roche Diagnostics, Laval, QC, Canada). The suspen-
sions were transferred into FastPROTEIN BLUE tubes
and were homogenized using a FastPrep apparatus (MP
Biomedicals, Solon, OH, USA). The suspensions were
homogenized using six cycles (40 s each) at power setting
6, with a 5-min cooling period on ice between each cycle.
The homogenates were then centrifuged at 15,000 × g for
15 min, and the supernatants were divided into aliquots
and stored at −80°C until used.
ProteinChip array processing
Two types of ProteinChip ion-exchange arrays (Q10 and
CM10; Bio-Rad Laboratories, Mississauga, ON, Canada)
were assembled in a 96-well bioprocessor (Bio-Rad La-
boratories) and were preactivated for 30 min with their
respective buffers (100 mM Tris–HCl, pH 9.0, and
100 mM sodium acetate, pH 4.0, respectively). Binding
buffers (180 μl) for the respective arrays were then
mixed with 20 μl of protein extract adjusted to a final
protein concentration of 0.5 mg/ml, and the mixtures
were incubated for 60 min. All the protein samples were
tested in duplicate. After two washes with binding buffer
and one quick rinse with HPLC-grade water the spots
were loaded twice with 1 μl of a saturated solution of
sinapinic acid dissolved in 50% acetonitrile (ACN)/0.5%
trifluoroacetic acid (TFA) (v/v). All the steps were carried
out at room temperature (18-20°C) using a Micromix-5
platform shaker and a Biomek 3000 robot-pipetting work-
station (Beckman-Coulter France, Villepinte, France). The
arrays were processed using a PCS 4000 ProteinChip
Reader (Bio-Rad Laboratories) programmed in positive
ion mode with an ion acceleration potential of 20 kV.
Spectra processing and statistical analysis
Once the spectra were calibrated and normalized using
the total ion current method, clusters of peaks with the
same mass were defined using the following settings: S/N
(first pass) ≥5, minimum peak threshold: 20%, mass error:
0.3%, S/N (second pass) ≥2. Three types of computer-
generated statistics performed using ProteinChip Data
Manager 3.0.7 software (Bio-Rad Laboratories) were used
to analyze the data (the non-parametric Mann-Whitney U
Table 1 Characteristics of S. suis strains serotype 2 used in the SELDI analysis
Strains ST Country Province/State Infection
P1/7 1* Europe NA**** Meningitis
MNCM01 1 Thailand Chiang Mai Endocarditis
MNCM06 1 Thailand Chiang Mai Meningitis
MNCM16 1 Thailand Chiang Mai Meningitis
MGGUS2 1 United States Wisconsin Meningitis
MGGUS3 1 United States Iowa Meningitis
NIAH11433 1 Japan NA Meningitis
DAT261 1 Japan Gunma Pneumonia
DAT264 1 Japan Gunma Meningitis
DAT229 1 Japan Aichi Endocarditis
P 517/03 P4 1 Argentina Buenos Aires Meningitis
P 477/03 P1 1 Argentina Cordoba Meningitis
P 613/05 P3 1 Argentina Buenos Aires Meningitis
31533 1 France Brittany Meningitis
SS166 1 France Brittany Meningitis
1043248 25** Canada Quebec Meningitis
1043629 25 Canada Quebec Pneumonia
1044423 25 Canada Ontario NA
1053253 25 Canada Manitoba Pneumonia
1085543 25 Canada Quebec Meningitis
MNCM04 25 Thailand Chiang Mai Meningitis
MNCM10 25 Thailand Chiang Mai Septicemia
MNCM24 25 Thailand Chiang Mai Endocarditis
MNCM26 25 Thailand Chiang Mai Meningitis, endocarditis
MNCM51 25 Thailand Chiang Mai Septicemia
MGGUS4 25 United States Iowa Septicemia
1102864 25 Canada Quebec Septicemia
1102337 25 Canada Quebec Meningitis
LPH4 25 Thailand Lamphun Septicemia
LPH12 25 Thailand Lamphun Septicemia
1054471 28*** Canada Manitoba Meningitis
1088563 28 Canada Quebec Meningitis
1097205 28 Canada Ontario Meningitis
1057906 28 Canada Saskatchewan Meningitis
MNCM43 28 Thailand Chiang Mai Endocarditis
MGGUS9 28 United States Oklahoma Endocarditis
MGGUS10 28 United States Illinois Pneumonia
MGGUS11 28 United States Virginia Pneumonia
MGGUS12 28 United States Iowa Pneumonia
DAT242 28 Japan Ibaraki Meningitis
DAT245 28 Japan Ibaraki Meningitis
DAT246 28 Japan Ibaraki Septicemia
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Table 1 Characteristics of S. suis strains serotype 2 used in the SELDI analysis (Continued)
1084708 28 Canada Ontario Septicemia
PAH-17 28 United States Minnesota Meningitis
DAT251 28 Japan Ishikawa Septicemia
*, All ST1 strains are mrp+, ef+, sly+; **, All ST25 strains are mrp-, ef-, sly-; ***, All ST28 strains are mrp+, ef-, sly-; ****, Not available.
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ical clustering method).
Protein purification and identification
The protein extracts were dialyzed overnight at 4°C
against a 1,000-fold volume of 20 mM Tris-HCl (pH 9.5).
They were then fractionated by ion-exchange chromatog-
raphy (IEX) using HiTrap Q HP columns (GE Healthcare
Life Sciences, Velizy-Villacoublay, France) as described
previously [34]. IEX fractions containing the target pro-
teins were further separated by reversed-phase high pres-
sure liquid chromatography (RP-HPLC; GE Healthcare
Life Sciences) according to Lanotte et al. [34]. The RP-
HPLC fractions were concentrated 20-fold in a vacuum
centrifuge (miVac, Genevac, Ipswich, England) to a final
volume of ~50 μl. Thereafter, 3 μl of the concentrate was
spotted on gold arrays (Bio-Rad Laboratories) and was an-
alyzed in the MALDI mode using a SELDI PCS 4000 ap-
paratus and the following acquisition protocol: focus mass
10,000; laser energy 3,000; matrix attenuation 2,500; parti-
tion 1/1; 20 shots. The fraction containing the target pro-
tein was dried completely in a vacuum centrifuge and was
then reconstituted in tricine sodium dodecyl sulfate (SDS)
sample buffer containing NuPAGE reducing agent (Invi-
trogen SARL, Cergy, France). The mixture was divided
into two samples that were heated at 40°C for 30 min and
separated in parallel on 1D home-cast Tris-Tricine gels
(18%T/6%C) at 30 V constant for 1 h followed by 60 mA
constant for an additional 15 h. Three lanes (two lateral
and one in the middle of the gel) were loaded with pre-
stained molecular weight (MW) markers, which served to
indicate the approximate position of the target proteins in
the unstained gel. One-mm-thick gel slices covering two
adjacent lanes containing the same protein were ex-
cised. Each gel slice was further divided into two equal
parts corresponding to one separate lane. One of the
slices was passively eluted to extract the target protein
as described previously [35]. Once the mass of the pas-
sively eluted target protein was confirmed on the gold
array, the protein in the corresponding second slice was
trypsin digested and LC-MS/MS microsequenced as de-
scribed previously [34].
Database search and processing of results
Data were searched using SEQUEST through a Bioworks
3.1.1 interface (ThermoFinnigan, San Jose, CA, USA)
against a subset of the NCBI non-redundant databaserestricted to S. suis entries (http://www.ncbi.nlm.nih.
gov/genome/genomes/199). Peak lists were extracted
using extract-msn (BioWorks 3.3.1 Thermo Scientific)
using the default settings. DTA files were generated from
MS/MS spectra that reached a minimal intensity (n =
100) and a sufficient number of ions (n = 5). The DTA
files allowed several MS/MS spectra corresponding to
the same precursor ion with a tolerance of 50 ppm to be
averaged. Spectra from peptides with molecular masses
between 600 Da and 4,500 Da were retained. The search
parameters were as follows: the mass accuracy of the
monoisotopic peptide precursor was set at 10 ppm and
the mass accuracy of the peptide fragments was set at
0.5 amu. Only b-ions and y-ions were considered for the
mass calculations. The oxidation of methionine (+16 Da)
was considered as a variable modification. Two missed
trypsin cleavages were allowed. Only peptides with Xcorr
values higher than 2.0 (double charge), 2.5 (triple
charge), and 3.0 (more than 3 charges) were retained. In
all cases, the peptide p-value was required to be below
0.001 and the DeltaCn value to be above 0.1. All protein
identifications were based on the detection of a mini-
mum of two distinct peptides. No false positives were
detected using these parameters. Shared peptides were
only counted for the proteins that had the most match-
ing peptides.
Results
The protein expression profiles of 45 S. suis serotype 2
strains obtained on two types of ProteinChip arrays
(CM10 and Q10) were submitted to multivariate heat-
map/hierarchical clustering and univariate analyses. Hier-
archical clustering was based on two main spectral
features of each detected protein: a qualitative feature (m/
z or mass-to-charge ratio; here z = 1, which means that m/
z directly reflects the mass [expressed in Daltons]) and a
semi-quantitative feature (intensity, expressed in μA per
laser pulse). Hierarchical clustering of the patterns was
generated with respect to the following criteria: (i) se-
quence type (ST1 versus ST25 versus ST28), (ii) continent
of origin (Far East Asia, including Japan and Thailand ver-
sus North America, including Canada and USA), (iii)
country of origin (Canada versus Japan versus Thailand
versus USA), and (iv) type of infection and pathological le-
sion (Group A - endocarditis/pneumonia/septicemia ver-
sus Group B - meningitis).
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tinent, country, and pathology was unsuccessful (see
Additional file 1: Figure S1, Additional file 2: Figure S2
and Additional file 3: Figure S3), the clustering of S. suis
protein profiles by ST generated a very high level of cor-
rect classification (Figure 1). The detailed view of the
heatmap on Figure 1 shows 136 proteins in the three
groups of S. suis strains defined by ST (ST1, ST25, and
ST28). Interestingly, hierarchical clustering provided a
100% correct classification of all fifteen ST1 and ST25
strains and thirteen of the fifteen ST28 strains (87% cor-
rect classification).
Some combinations of biomarkers (arbitrarily delim-
ited by yellow- and grey-bordered rectangles on Figure 1)
made it possible to delineate the groups from each other.
However, none of the combinations was completely
homogenous in terms of over-expression (or up-
regulation) or under-expression (or down-regulation)
(red and green boxes in the respective rectangles). An-
other practical consideration was that the number of
candidate biomarkers turned out to be too large to be of
use for further purification and identification in aca-
demic laboratories such as ours. In addition, while
multivariate clustering has the advantage of providing a
global overview of the profiles, it does not allow a pre-
cise quantification of expression. In practice, the usual
colors of the rectangles on the heatmaps (red standing
for over-expression or up-regulation, green for under-
expression or down-regulation, and black for no differ-
ence) are nuanced as more or less dark.
The same spectra were analyzed by the Mann–Whitney
(applicable to two groups of data sets only) and Kruskal-
Wallis (applicable to more than two groups; in our study -
three or four) tests to limit the number of the candidate
biomarkers and to evaluate their expression levels more
precisely while trying to select the most statistically dis-
criminating ones for further purification and sequencing.
The statistical comparisons were made point-by-point,
that is, for candidate biomarkers with the same mass
whose statistically significant variations in intensity were
calculated either for S. suis groups defined by their ST or
other criteria such as strain origin and pathology. Four se-
lection criteria with respect to the S. suis strains that were
discriminated by their ST (Figure 2) as well as by contin-
ent, country of origin, or pathology (Additional file 4:
Table S1, Additional file 5: Table S2 and Additional file 6:
Table S3) were compared using a multivariate analysis.
However, unlike the multivariate analysis where discrimi-
nated protein profiles were correlated only with the ST of
the S. suis strains, the univariate Mann–Whitney and
Kruskal-Wallis analyses revealed candidate biomarkers in
all cases. It should be noted that only the most statisti-
cally significant candidate biomarkers in Figure 2 and
in Additional file 4: Table S1, Additional file 5: Table S2and Additional file 6: Table S3 are presented (9 in Figure 2;
24, 30, and 12 in Additional file 4: Table S1, Additional file
5: Table S2 and Additional file 6: Table S3, respectively).
Figure 2 shows the nine most discriminating proteins
found in the S. suis strains divided by ST. Of these, two
were overexpressed in ST1 (5,958 Da and 10,249 Da), four
in ST25 (5,989 Da, 6,646 Da, 7,421 Da, and 9,825 Da), and
three in ST28 (4,516 Da, 7,833 Da, and 9,342 Da). Inter-
estingly, only two of the biomarkers in Figure 2 were
found statistically significant when all strains were com-
pared by combining ST and type of pathology in two
groups: group A (heart/lung/sepsis) and group B (menin-
gitis/brain). The first is p5958, which was overexpressed
in the S. suis ST28 strains (Figure 2), as well as in strains
isolated from pigs/humans with meningitis (Additional file
6: Table S3). The second is p5989, which was overex-
pressed in the S. suis ST1 strains (Figure 2) and in strains
isolated from pigs/humans with cardiac and pulmonary
pathologies or sepsis (Additional file 6: Table S3).
As a next step, we tried to purify and identify the most
promising candidate biomarkers. They were purified
using several purification steps, including IEX, RP-
HPLC, and 1D SDS-PAGE. All the fractions obtained
throughout the purification procedure were systematic-
ally tested for the presence of target proteins by SELDI
(IEX fractions), MALDI (RP-HPLC fractions, and passive
elution (1D SDS-PAGE gel slices). The purified proteins
were trypsinized, identified by LC-MS/MS, and submit-
ted to an in silico comparison of the masses of the pep-
tides to the masses in the proteome database of 19 S.
suis reference strains with completely sequenced ge-
nomes and 75 strains from the same taxon whose ge-
nomes are currently being sequenced (http://www.ncbi.
nlm.nih.gov/genome/genomes/199). We eventually suc-
ceeded in identifying two of the proteins (p4516 and
p9342) as a putative ATP-binding cassette (ABC) trans-
porter and a nucleoid-DNA-binding protein, respectively.
Discussion
Compared to studies that are usually performed on a
limited number of bacterial strains, population-based
studies seem to be a more appropriate approach for
identifying species-specific biomarkers. Our study on a
population of 45 S. suis serotype 2 strains is thus more
representative of species whose main genotypes have
already been defined by MLST. The search for candidate
biomarkers has benefited from the advent of mass spec-
trometry, which has also proven to be a promising and
reliable approach for classifying bacteria. Several tech-
niques are currently being used, including MALDI-TOF-
MS, LC-ESI-MS, and SELDI-TOF-MS [32-35]. When
applied to the characterization of complex protein sam-
ples (bacterial extracts, for example), approximately 100
proteins can be detected by MALDI and SELDI while
Figure 1 (See legend on next page.)
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Figure 1 Heatmap/hierarchical clustering of 136 proteins of 45 S. suis strains discriminated by MLST into three sequence type (ST)
groups: ST1 (n = 15), ST25 (n = 15), and ST28 (n = 15). The clusters were obtained by combining the average intensity values of all samples
tested in duplicate on CM10 and Q10 ProteinChip arrays (acquisition protocol 1). The consecutive numbers of each strain used in the SELDI
expression difference mapping (EDM) are indicated above the image (S1-S15 for the ST1 group (in red); S16-S30 for the ST25 group (in blue), and
S31-S45 for the ST28 group (in green) followed by the respective sequence types and original names of the S. suis strains (in brackets). The protein
masses detected on the CM10 (red) and Q10 (blue) ProteinChip arrays are indicated on the right side of the image. Specific EDM conditions: First pass:
peak S/N≥ 5, valley depth S/N≥ 3, minimal peak threshold – 20% for all spectra; second pass: peak S/N≥ 2, valley depth S/N≥ 2; third pass: adding
estimated (missing) peaks to complete the clusters, clustered mass window width – 0.1%, autocentroid marks on peaks, M/Z range of analysis
(z = 1): 3000–20000 Da.
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ESI-MS. However, LC-ESI-MS has the reputation of be-
ing labor intensive and time consuming and of requiring
multiple replicates [36]. In our study, we used SELDI in
which proteins and their fragments are characterized by
their m/z, and their abundance is estimated in a semi-
quantitative manner by the level of protein expression.
The limitations of the present study arise from the fact
that it does not take into consideration extracellular pro-
teins as well as cell proteins that are not expressed
under the bacterial growth conditions used. In addition,
SELDI is more adapted for proteins with a molecular
mass of less than 30 kDa.
The EDM of proteins based on their relative abun-
dance (as deduced from measured values of μA laser/
pulse) was done in extracts from bacterial cells grown in
parallel under the same culturing condition, without any
specific induction of protein expression. All tested 45 S.
suis strains were divided in three groups by sequence
type and the level of average protein expression was
evaluated in a comparative way, within the frame ofFigure 2 Candidate biomarkers of S. suis selected by univariate analythese three STs. It is noteworthy that the level of expres-
sion of a particular protein, measured in one ST group
of fifteen strains, could in fact represent a normal level
for this ST, but be considered as high and/or low com-
pared to the two other ST groups.
Two peptides that were overexpressed in ST28 strains
(compared to those of ST1 and ST25 groups) were puri-
fied and identified, p4516 and p9342. The first one,
p4516, was a fragment of an uncharacterized protein of
S. suis, i.e. “hypothetical protein Ssui0_06242 [Strepto-
coccus suis 05HAS68]”. Its BLAST analysis revealed se-
quence homology (ca. 40% identity) with a family of
ATP-dependent transmembrane proteins involved in the
translocation of substrates across the bacterial mem-
brane. Interestingly, except for S. suis 05HAS68 where
this putative ABC transporter was identified, sequence
homologies were all related to ABC transporters of other
streptococci taxa, such as S. agalactiae and S. oralis
(Additional file 7: Table S4). The second one, p9342, was
a fragment of a putative nucleoid DNA-binding protein,
which may play a role in genome maintenance and genesis of two or three groups of strains divided by sequence type.
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nucleoid DNA-binding protein is very highly conserved
across different S. suis clinical isolates (100% identity
in 17 S. suis strains), and, to a lesser extent, in other
streptococci and lactobacilli (Additional file 7: Table S4).
Further studies are required to determine why these pro-
teins are over-expressed by less virulent strains of S. suis.
One hypothesis is that they may be the products of anti-
virulence genes, which are known to interfere with bacter-
ial virulence [37]. For instance, Zhao et al. [38] identified
the ArgT protein as an anti-virulence factor since it inter-
feres with the virulence of Shigella flexneri by transporting
specific amino acids or by modulating the expression of
the protease HtrA.
Conclusions
In summary, SELDI analysis of 45 strains of S. suis
allowed to identify nine statistically significant proteins
that can be specifically correlated with either ST1, ST25
or ST28. The possible involvement of the overexpressed
proteins in the pathology of S. suis infections will require
further investigation.
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